Seelos Therapeutics
SEEL
#10721
Rank
S$0.27 M
Marketcap
S$0.48
Share price
-31.49%
Change (1 day)
-98.18%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): S$6.01 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$48.61 Million, an increase over its 2022 earnings that were of -S$94.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$6.01 M-112.37%
2023 -S$48.61 Million-48.58%
2022 -S$94.52 Million14.07%
2021 -S$82.86 Million240.34%
2020 -S$24.35 Million-62.76%
2019 -S$65.38 Million587.73%
2018 -S$9.51 Million-36.54%
2017 -S$14.98 Million74.83%
2016 -S$8.57 Million-63.26%
2015 -S$23.33 Million-18.06%
2014 -S$28.47 Million46.19%
2013 -S$19.47 Million-31.67%
2012 -S$28.5 Million
2010 -S$26.7 Million448.63%
2009 -S$4.87 Million-25.83%
2008 -S$6.56 Million-45.65%
2007 -S$12.07 Million2.82%
2006 -S$11.74 Million-41.86%
2005 -S$20.19 Million-9.27%
2004 -S$22.25 Million114.92%
2003 -S$10.36 Million-70.78%
2002 -S$35.44 Million60.2%
2001 -S$22.12 Million70.3%
2000 -S$12.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA